Literature DB >> 26185054

Geometric analysis of an expandable reamer for treatment of avascular necrosis of the femoral head.

Stefan Landgraeber1, Thanh Ngoc Tran2,3, Tim Claßen2, Sebastian Warwas2, Jens Theysohn4, Andrea Lazik4, Marcus Jäger2, Wojciech Kowalczyk3.   

Abstract

"Advanced core decompression" (ACD) is a treatment option for osteonecrosis of the femoral head (ONFH) that aims at complete removal of the necrotic tissue using a percutaneous expandable reamer and refilling of the head with an osteoconductive bone-graft substitute. The objective of this study was to evaluate if the success of ACD depends on the amount of necrotic tissue remaining after the procedure and how efficiently the necrotic tissue can be removed with the current reamer. Three-dimensional models of proximal femora including ONFH were generated from the preoperative MRIs of 50 patients who underwent ACD. Best-case removal was calculated by geometrical analysis. In 28 of 50 cases, postoperative MRI was used to determine how much necrotic tissue had been removed. Prognostic values and correlations were evaluated in order to assess success or failure of the treatment. The amount of preoperative and remaining necrosis correlates significantly with treatment failure. The larger both volumes are, the more likely it is that treatment will fail. In patients with remaining necrosis of less than 1000 mm(3), no treatment failure was observed. The amount of necrosis actually removed differed significantly from the amount calculated as the best possible result. Simulation of the removal procedure showed that complete removal is not possible. These results led to the conclusion that the success of ACD depends on the amount of necrotic tissue remaining in the femoral head after the procedure. Modifications to the instrument are necessary to increase the amount of necrotic tissue that can be removed.

Entities:  

Keywords:  Core decompression; Hip; Osteonecrosis of the femoral head

Mesh:

Year:  2015        PMID: 26185054     DOI: 10.1007/s00402-015-2287-6

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  6 in total

1.  Aspects of postoperative magnetic resonance imaging of patients with avascular necrosis of the femoral head, treated by advanced core decompression.

Authors:  Andrea Lazik; Stefan Landgraeber; Tim Claßen; Oliver Kraff; Thomas C Lauenstein; Jens M Theysohn
Journal:  Skeletal Radiol       Date:  2015-06-21       Impact factor: 2.199

2.  Hip osteonecroses treated with calcium sulfate-calcium phosphate bone graft substitute have different results according to the cause of osteonecrosis: alcohol abuse or corticosteroid-induced.

Authors:  Andrzej Sionek; Adam Czwojdziński; Jacek Kowalczewski; Tomasz Okoń; Dariusz Marczak; Marcin Sibiński; Marcin Złotorowicz; Jarosław Czubak
Journal:  Int Orthop       Date:  2018-03-17       Impact factor: 3.075

3.  Modifications to advanced Core decompression for treatment of Avascular necrosis of the femoral head.

Authors:  Stefan Landgraeber; Sebastian Warwas; Tim Claßen; Marcus Jäger
Journal:  BMC Musculoskelet Disord       Date:  2017-11-21       Impact factor: 2.362

4.  Multiple drilling is not effective in reducing the rate of conversion to Total hip Arthroplasty in early-stage nontraumatic osteonecrosis of the femoral head: a case-control comparative study with a natural course.

Authors:  Zunhan Liu; Xuetao Yang; Yuhan Li; Wei-Nan Zeng; Enze Zhao; Zongke Zhou
Journal:  BMC Musculoskelet Disord       Date:  2021-06-12       Impact factor: 2.362

5.  Investigating Clinical Failure of Bone Grafting through a Window at the Femoral Head Neck Junction Surgery for the Treatment of Osteonecrosis of the Femoral Head.

Authors:  Wei Zuo; Wei Sun; Dingyan Zhao; Fuqiang Gao; Yangming Su; Zirong Li
Journal:  PLoS One       Date:  2016-06-10       Impact factor: 3.240

6.  The effect of robot-navigation-assisted core decompression on early stage osteonecrosis of the femoral head.

Authors:  Benjun Bi; Shudong Zhang; Yuchi Zhao
Journal:  J Orthop Surg Res       Date:  2019-11-21       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.